Course Description
This session introduces psychodermatology, an under-recognized field that explores the bidirectional relationship between psychological factors and skin disease. Learners will examine the high prevalence of psychiatric comorbidities in dermatology and classification of psychodermatologic disorders. The webinar highlights current practice gaps, including limited clinician training, restricted access to specialty care, and a lack of robust evidence to guide treatment. Participants will learn how integrated care models unite dermatology, psychiatry, psychology, and psychiatric pharmacy, and support individualized pharmacologic and nonpharmacologic management. By the end of the session, learners will be equipped to apply psychodermatology principles in practice, improving holistic, collaborative, and empathetic care for patients with overlapping dermatologic and psychiatric needs.
Learning Objectives
- Describe the bidirectional relationship between skin and mental health.
- Assess psychotropic and dermatologic treatment–related adverse effects.
- Outline a comprehensive treatment plan for psychocutaneous disorders, including pharmacotherapy, psychotherapy, and holistic approaches.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Faculty
View biographical information
Mohammad Jafferany, MD, DFAPA, MCPS
Professor, Psychodermatology, Psychiatry & Behavioral Sciences
Covenant HealthCare College of Medicine at Central Michigan University | CMU Medical Education Partner
Dr. Mohammad Jafferany is Professor of Psychodermatology, Psychiatry and Behavioral sciences at Central Michigan University College of Medicine. He has combined training in Dermatology and Psychiatry. He is president of Association for Psychocutaneous Medicine of North America. He has more than 220 scholarly texts and publications to his credit on various topics in psychodermatology in peer reviewed journals. He has edited and authored 12 books on different topics of Psychodermatology such as Pediatric psychodermatology, geriatric psychodermatology, Stress and Skin, Trichotillomania, Essentials of Psychodermatology, Handbook of Psychodermatology, Psychotrichology, and Clinical Psychodermatology, besides contributing chapters on Psychodermatology in various textbooks. Three of his books are translated into Russian, Chinese, and Turkish languages. He has conducted International Psychodermatology workshops and Master Courses in different parts of the world. He is a visiting professor of Psychodermatology in Capital Medical University Beijing, China. He is currently the chairperson of World Psychodermatology Day and was Co-Chair of recently held 1st World Congress of Psychodermatology 2025. He is member of board of directors of internation society of dermatology.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Dates: # - #
ACPE Contact Hours: #.##
ACPE Number: 0284-0000-##-###-###-P (Application)
 | The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
View Faculty and Program Planning Committee Disclosures of Interest
Faculty: Mohammad Jafferany, MD, DFAPA, MCPS discloses speaker honorarium from La Roche Posay and Boehringer Ingelheim
Planning Committee: Members and disclosures listed here.
View AAPP's Disclaimer and Disclosure Declarations
AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Unlabeled Use Disclosure: Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
View AAPP's Privacy Policy
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View AAPP's Fair Balance and Integrity Statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.